Papers & Contributions

  1. Fayz El-Kenawy, Afaf Abdel-hafez, Mohamed Ghoneam, Hala Abdel-Hafez and Mohamed Atwa. Brothers of Women with Polycystic Ovary Syndrome: A group with high Risk for type 2 Diabetes Mellitus and Cardiovascular Diseases Studied in Egyptian Population; The International Journal of Medicine, 2009 Vol.2 , Issue1.
  2. Ayman Abdel-Ghafar and Afaf Abdel-hafez. Esophageal Dysmotility in Diabetic Patients with Varices; Arab Journal of Gastroenteroloegy 11(2010) : 192-196.
  3. Maha El-Gayar, Manal Ibrahem, Afaf Abdel-hafez, Neven Omran and Eman Aamer. Evaluation of Thyroid Hormone Abnormalities and Thyroid Autoantibodies in Chronic Idiopathic Urticaria and Alopecia Areata Egyptian patients; Asian Journal of Dermatology, 3 (1): 1-12, 2011.
  4. Eman El-Safty, Medhat Sakrana, Afaf Abdel-hafez, Ayman Abdel-Samad, Adel El-Gamal, Mohamed Foda, Maged Zaghlol, Osama Hamza Yaser El-Ghonemy and Mohamed Regal. Assessment of Mitral Valve Area From long axis and Apical 4-Chamber Echocardiographic Views: Correlation with Direct intra – Operative Measurements. Research Journal of Cardiology, 4(1): 1-15,2011.
  5. Waleed El-Dars, Afaf Abdel-hafez, Medhat M. ALy and Wafaa K. Mowafy. Staphylococcal Food Poisoning in Mansoura University Hospitals; Journal of Tropical Medicine, Accepted in 10-6-2010 - Vol.11 No.3 August, 2010.
  6. Afaf Abdel-hafez and Nadya Hasanen. Impact of normoglycemia on mortality in intensive care unit :ِA prospective study from Mansoura Emergency Hospital; European Journal of dentistry and medicine 3 (1): 12-22, 2011.
  7. Salah Aref, Tarek Selem, Nadya El-Menshawy, Lamyaa Ibrahem, Doaa Abdel-Allah, Manal Foda, Nashwa ABu-Samra, Ayman Menesy, Hassan Abdel-Ghafar, Insaf Bassam and Mohamed Abdel-Wahab.Antiplatelet Antibodies Contribute To Thrombocytopenia Associated With Chronic Hepatitis C Virus Infection; Hematology 2009 Vol. 14 No. 5 277-281
  8. Salah Aref, Nadya El-Menshawy, Doaa Abdel-Allah, Manal Foda, Ayman Menesy, Insaf Bassam, Emad Azmy and Mohamed EL-Refaee. Neutrophil Apoptosis in Neutropenic Patients With Hepatitis C Infection: Role of Caspases 3, 10 and GM-CSF; Indian Journal of Hematology and Blood Transfusion (7 June 2011), pp. 1-7.
  9. Sabry A, Hassan R, Mahmoud I, Hamed M, Sobh M. Proteinuria after kidney transplantation: its relation to hepatitis C virus and graft outcome.. Iran J Kidney Dis. 2007 Oct;1(2):88-97.
  10. Shiha.G, Samir.W, Zalata.K, Zaki.M, Elbeeh.A, Attalah,A. Performance of European Liver Fibrosis (ELF) Markers in Patients with Chronic Hepatitis C Genotype 4. Hepatology International. Feb 2009. (Abstract).
  11. Shiha.G, Samir.W, Zalata.K, Zaki.M, Elbeeh.A, Attalah,A. Performance of fibro-test in patients with chronic hepatitis C genotype 4. Hepatology International. Feb 2009. (Abstract)
  12. Gamal shiha. Editorial. Serum hyaluronic acid: A promising marker of hepatic fibrosis in chronic hepatitis B. The Saudi Journal of gastroentrology. Vol 14 No. 4 October 2008. 
  13. Shiha G, Elshenawy.H, Samir.W., et al. The need for liver biopsy is decreased using a simple score (Fibrofast) of hepatic fibrosis in patients with chronic hepatitis C (poster) 43rd Annual meeting of the European Association for the study of the liver. Italy, Milan, April 2008.
  14. Shiha G, Carvalho Filho R, SebastianiG., et al. Multicentre Validation of A Simple Score For Prediction of Sever Hepatic Fibrosis.Hepatology International. March, 2007. 
  15. Shiha G, Abdelkhalek E, Farouk D. et al. Virological Response of Peginterferon Alfa-2a Plus Ribavirin for Chronic Hepatitis C Genotype 4. Hepatology International. March, 2007.
  16. Attallah AM, Toson E., Shiha G.,et al. Evaluation of serum procollagen Aminoterminal Propeptide III, Lamimin, and Hydrroxyproline as predictors of Severe Fibrosis in patients with Chronic Hepatitis C. Journal of Immunoassy and Immunochemistry, 28: 199-211,2007.
  17. Attallah AM, Zahran F., Shiha G.,et al. Immunochemical identification and detection of serum fibronectin in liver fibrosis patients with chronic Hepatitis C. Journal of Immunoassay and Immunochemistry, 28: 331-342, 2007.
  18. Attallah AM, Ismail H.,  Shiha GE., et al.   Immunochemical Identification and partial characterization of a native hepatitis C viral non- structural 4 antigen in sera of HCV infected patients.  Clinical Chemica Acta.2007.
  19. Shiha G., Samir W., Zalata K., et al.,  Characterization of identically detected asymptomatic hepattis B positive subjects in Egypt. Arab Journal astroentrology 2007; 8(3): 74-79. 
  20. Attallah AM, Shiha GE, Omran MM, Zalata KR. A discriminant score based on four routine laboratory blood tests for accurate diagnosis of severe fibrosis and/or liver cirrhosis in Egyptian patients with chronic hepatitis C. Hepatology Research. 2006 Feb 11.
  21. Shiha G, Seham S, Zalata K. Hepatic steatosis in chronic hepatitis C virus infection genotype 4: prevalence and clinical correlations. Liver International. (26) 80, September 2006.
  22. Shiha G, Abass A, Elshinawy H, and Zalata K.Sustained virological response of peg-interferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. Liver International. (26) 81, September 2006.
  23. Shiha G, Elshinawy H, Zalata K., et al. Peg-interferon alfa-2b plus riavirin for the treatof chronic hepatitis C genotype 4. Liver International. (26) 79, September 2006.
  24. Abdelfattah MH, Rashed MA, Shiha G., et al. Endoscopic variceal ligation versus pharmacologic treatment for primary prophlaxis of variceal bleeding: a randomized study. Hepatology International. (44) 83, April 2006.
  25. Shiha G, Samir W, Zalata K.Charecterization of patients of coinfected by hepatitis B and hepatitis C viruses. Hepatology International. (44) 176, April 2006.
  26. Attallah A., Toson E., Shiha G., et al. Discriminant function based on Hyaluronic acid and its degrading enzymes and degradation products for differentiating cirrhosis from non-cirrhotic liver diseased patients in chronic HCV infection. Clinical Chemica Acta, 2006.
  27. Shiha G., Khaled RZ., Abdullah AF., Mohamed MK.  Immunohistochemical identification of HCV target antigen in paraffin-embedded liver tissue: reproducibility and staining pattern. Liver International(25) 1 – 7, 2005.
  28. Mohamed. I., Elhabashi. A., Elsawy. E., Elhusseini. A., Shiha. G, et al. The Impact of Hepatitis C virus Viremia on renal graft and patient survival: A 9 – year prospective study. American Journal of kidney diseases, vol 43, No 1, 2004: pp 131 – 139.
  29. Shiha G., AbdAllah.A, Camelia A, Abdel Malak, Nabih A, Elghawalby, Ahmed S Shehatta, Mohamed Abdel-Raouf . Identification of a specific Marker for hepatitis C virus infection using capillary Zone electrophoresis. Clinical chemica  Acta (236) 171-179, 2004.
  30. Shiha G., Zalta. K, Abd-Allah.A, Mohamed.M. Utility of a novel HCV-NS4 antigen detection immunoassay for monitoring treatment of HCV- infected individuals with pegylated interferon α-2a. Hepatology Research, 28, 68-78, 2004.
  31. Shiha. G., Attalah. A. ,  Ismael. H ,  Tabel. A., Eldesouky I. A Novel Antigen Detection Immunoassay for field Diagnosis of Hepatitis C virus infection. Journal of Immunoassay & immunochemistryVol.24. No.4 PP.395-407, 2003.
  32. Shiha G., Zalata. Kh. et al.,Does Schistosomasis interfere with application of knodell score for assessment of chronic hepatitis-C, Medical Science Monitor, 8 (2) 72-77, 2002.
  33. Shiha. G., Salem. S. et al., Gastric variceal ligation:A new technique, Gastrointestinal Endoscopy, volume 49, No.4, part 1, 1999.
  34. Salem. S., G. Shiha, M. Hamed, F. Mohamed, F. Azam. Sclerotherapy versus sclerotherapy and propranolol in the prevention of rebleeding from oesophageal varices:a randomized study. Gut, 38: 770-7741996.
  35. Ata. A., G. Shiha, S El-Morsy G El-Abady. Detection of schistosoma circulating antigen before and after praziquantel chemotherapy using fast dot ELISA; Journal of Hepatology, Gastroenterology and Infectious Diseases, 4:35-43, 1995.
  36. G. Shiha, M. Hamed, S. Salem, F. Mohamed, H. Askalany. Octerotide infusion plus emergency sclerotherapy versus sclerotherapy alone for the control of bleeding oesophageal varices: A prospective randomized clinical trial; Endoscopy, 28:S35, (Abstract 1066), 1996.
  37. G.Shiha, M.Hamed, H.ElAskalany, Ayman Menesy, S.Salem et al.,    Mononitrates and combination of mononitrates and propranolol as adjuvant to sclerotherapy for the prevention of rebleeding from esophageal varices,  Digestion, 59(suppl.31), 1-820 Abstract No. FoLM2512, 1998.
  38. G. Shiha, S. Salem, F. Mohamed, M. Hamed, O. El-Baz. Prevalence of hepatitis C in patients with bleeding oesophageal varices: Clinical significance and impact the outcome of sclerotherapy. Triennial International Symposium on Viral Hepatitis and Liver Diseases, Abstract C 25, 1996.
  39. Ehab E. Abdel-Khalek, Ashraf El-Fakry, Mohamed Helaly, Magdy Hamed and Osama El-Baz. Systemic inflammatory response syndrome in patients with liver cirrhosis; The Arab Journal of Gastroenterology 2011 (12): 173-177 and Journal of Hepatology 2011, S61 (Abstract 138).
  40. Ehab E. Abdel-Khalek, Ashraf El-Fakry, Mohamed Helaly, Ibrahem Abdel-Aal and Khaled Zalata. Alanine aminotransferase levels in citizens of Nile Delta infected with the chronic hepatitis C; European Journal of General Medicine 2012 (December) Vol. 9(4).
  41. Ashraf El-Fakry, Ehab E. Abdel-Khalek, Sahar El-Gharabawy, Eman el-Tanihy and Aza Abdel-Bakey. Predictive Value of Adiponectin to Leptin Ratio for Diagnosis of Steatohepatitis in Patients with Non-alcoholic Fatty Liver Disease. Accepted as electronic poster & paper poster presentation at the 47th annual meeting of the European Association for the Study of Liver (EASL), Barcelona (April) 2012 and Journal of Hepatology 2012, S507 (Abstract no 1286).
  42. Gamal Shiha, El-Sayed Abdel-Maksoud and Ashraf El-Fakry. Endoscopic band ligation compared to cyanoacrylate injection for management of bleeding gastric varices: a randomized controlled study; The Egyptian Journal of Gastroenterology, Vol. (19), No (1), January 2009 and Poster presentation at the 20th conference of APASL 2010, China, Beijing, March 24-28.
  43. Maha M Maher, Mahmoud I Nassar. Black esophagus: a case report; Cases Journal 2008, 1:367, 2008.
  44. Maha M. Maher , Somaya H. Soloma . Assessment of Thrombophilic Abnormalities During The Active State Of Inflammatory Bowel Disease. Saudi Journal of gastroenterology October 2008,     vol.14 (4):192-7.
  45. Maha M. Maher and  Mahmoud I. Nassar. Acute Cytomegalovirus Infection Is a Risk Factor in Refractory and Complicated Inflammatory Bowel Disease. Dig Dis Sci .2009.
  46. Maha M. Maher, Amany H. Mansour. Study of chronic hepatopathy in living Adults. Gastroenterology Research Vol. 2, No. 6,2009.
  47. Maha M. Maher,Basma A. Dessouky. Simplified early predictors of severe acute pancreatitis: a prospective study. Gastroenterology Research Vol. 3, No. 1, Feb2010.
  48. Maha M. Maher,Amr A. Darwish.Study of Respiratory Disorders  in Endoscopically Negative and Positive Gastroesophageal Reflux Disease; Four years experience in a major tertiary hospital. Saudi Journal of Gastroenterology. Volume no. 16, Issue 2, April-June 2010.
  49. Maha M Maher. Traditional and non Traditional Treatments of Crohn’s Disease . Open Journal of Gastroenterology. 2011.
  50. H A Almenir ,H H. Al Menshawy, M M. Maher, S Al Gamal. Oxidative Stress in Inflammatory Bowel Disease. Frontiers in Bioscience E4, 1335-1344, January 1, 2012.
  51. Maha M Maher. Inflammatory Bowel Disease: Review and Future View. Frontiers in Bioscience E4, 1638-1647, January 1, 2012.
  52. El-Nahas MR : Antioxidant therapy in diabetes -Where Are We Now?. CLINICAL DIABETES (MIDDLE EAST EDITION). 4 (3): 148-150, 2005.  www.onlinediabetes.net/clinicaldiabetesme/volume4%20number3.pdf
  53. Omar N, El-Nahas MR and Gray J: Novel antibiotics for the management of diabetic foot infections. International Journal of Antimicrobial Agents. 31: 411–419, 2008.
  54. El-Nahas MR: Management of diabetic foot infections. Modern Medicine. 27(6): 42-46, 2010
  55. Gawish H, Tarshwby, M, Setit O and El-Nahas MR: Diabetic foot should not be overlooked in swarming outpatient setting. Poster presentation at the joint meeting of the DFSG and NEURODIAB, 2-5 September, 2004, University Clinic, Regensburg, Germany.
  56. Mamdouh El-Nahas, Hanan Gawish, Manal El-Tarshoby, Omnia State and Mohamed Atwa: Plasma homocysteine concentartions in diabetic foot ulcer Patients. Poster presentation at the DFSG Conference Greece 7 -10 September 2005.
  57. Mamdouh El-Nahas, Hanan Gawish, Manal Tarshoby and Omnia State: The prevalence of foot ulcer risk  factors in Egyptian diabetic patients. Oral presentation at the DFSG conference which takes place in Elsinore, Denmark  from 10.-13. September 2006.
  58. Mamdouh El-Nahas, Hanan Gawish, Manal Tarshoby and Omnia State: The prevalence of foot ulcer risk  factors in Egyptian diabetic patients. POSTER presentation at the 42nd EASD Annual Meeting, Copenhagen, Denmark Thursday, 14 - Sunday, 17 September 2006 and published in Diabetologia. 49: (Suppl 1):  682, 2006 .
  59. Mamdouh El-Nahas, Hanan Gawish, Manal Tarshoby and Omnia State: Effects of simulated minor leg-length discrepancy on plantar pressure distribution in diabetic patients with neuropathic foot ulceration. Oral abstract presented at the DFSG conference which take place in Bled Sloveniafrom 25-28 September 2009.
  60. Mamdouh El-Nahas, Hanan Gawish, Manal Tarshoby, Omnia State, Mohamad Motawea and  Azza Abd Al-Baky: Inflammatory markers of cardiovascular risk among diabetic patients with neuropathic foot ulceration. Oral abstract presented at the DFSG conference which take place in Uppsala, Sweden from 17-19 September 2010.
  61. Mamdouh El-Nahas, Hanan Gawish, Azza Abd Al-Baky and Talal Amer: Endothelial dysfunction in diabetic subjects with neuropathic foot ulceration. Abstract presented at 47th EASD Annual Meeting which take place in Lisbon, Portugal from 12 to 16 September 2011. Published in Diabetologia volume 54 supplement 1, PP 469, 2011 (Abstract volume).
  62. Mamdouh El-Nahas, Hanan Gawish, Manal Tarshoby, Omnia State and Boulton AJM: The prevalence of risk factors for foot ulceration in Egyptian diabetic patients. Practical Diabetes International.  25(9):362-366,  2008.
  63. Mamdouh El-Nahas, Hanan Gawish, Manal Tarshoby, Omnia State: The impact of topical phenytoin on recalcitrant neuropathic diabetic foot ulceration. Journal of Wound Care, Vol. 18 (1):  33 – 37, 2009
  64. Mamdouh El-Nahas, H.M. Gawish, M.M. Tarshoby, O.I. State, A. Aboelyazid:  Effect of simulated leg length discrepancy on plantar pressure distribution in diabetic patients with neuropathic foot ulceration. Journal of Wound Care 20(10): 473 - 477 (Oct 2011).
  65. Mamdouh El-Nahas, Chapter in book: The Effect of Ethnicity on the Incidence of Foot Complications in Diabetes Mellitus in Egypt. In: Race and Ethnicity: Cultural Roles, Spiritual Practices and Social Challenges. Jonathan K. Crennan ed. Nova Publisher, chapter 16 PP 349-361, 2010. ISBN 978-1-60692-099-2
Submit to FacebookSubmit to Google PlusSubmit to TwitterSubmit to LinkedIn

Contact Us

Mansoura,  Elgomhoria st, Mansoura University, Specialized Medical Hospital, 35516

Tel.: 050 2234095 050 2230278
Fax:  050 2230129
email This email address is being protected from spambots. You need JavaScript enabled to view it.